Background: Infection with SARS-CoV-2 leads to COVID-19 which can manifest in various
ways from asymptomatic or mild disease to acute respiratory distress syndrome. The …

ABSTRACT Introduction SARS-CoV-2, the causative agent of COVID-19, attacks the
immune system causing an exaggerated and uncontrolled release of pro-inflammatory …

Although the precise pathogenesis of coronavirus disease 2019 (COVID-19) currently
remains unknown, its complex nature is gradually being revealed. COVID-19 is a disease …

Hemostatic derangement is a hallmark in severe COVID-19. Markedly elevation of D-dimer
and fibrinogen degradation product levels were observed in patients with severe COVID-19 …

An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …

Abstract Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world.
The range of the disease is broad but among hospitalized patients with COVID-19 are …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has not only challenged
global health systems but also spurred intense scientific inquiry into its pathophysiology …

Abstract Coronavirus disease 2019 (COVID-19), caused by a severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), can cause life-threatening pathology characterized …

Hypercoagulability has emerged as a prominent consequence of COVID-19. This presents
challenges not only in the clinic, but also in thrombosis research. Health and safety …

Critical COVID-19, like septic shock, is related to a dysregulated systemic inflammatory
reaction and is associated with a high incidence of thrombosis and microthrombosis …